Solventum Corp Files 8-K: Other Events & Financials

TL;DR

Solventum Corp (spun from 3M) filed an 8-K on Aug 15th covering events from Aug 13th. Standard disclosure stuff.

AI Summary

Solventum Corporation, formerly 3M Health Care Co., filed an 8-K on August 15, 2025, reporting on events as of August 13, 2025. The filing primarily concerns "Other Events" and includes "Financial Statements and Exhibits." Solventum Corporation is incorporated in Delaware and its principal executive offices are located at 3M Center, Building 275-6W, St. Paul, MN.

Why It Matters

This 8-K filing provides official updates and disclosures from Solventum Corporation, which is crucial for investors and stakeholders to understand the company's current status and any significant events.

Risk Assessment

Risk Level: low — This filing appears to be a routine disclosure of events and financial statements, not indicating any immediate or significant risks.

Key Numbers

• 001-41968 — SEC File Number (Identifies the company's filing with the SEC)
• 92-2008841 — IRS Employer Identification No. (Tax identification number for the company)

Key Players & Entities

• Solventum Corporation (company) — Registrant
• 3M Health Care Co. (company) — Former name
• 3M Company (company) — Related entity for business and mail address
• August 13, 2025 (date) — Earliest event reported
• August 15, 2025 (date) — Date of report
• Delaware (jurisdiction) — State of incorporation
• St. Paul, MN (location) — Principal executive offices

FAQ

From the Filing

0001140361-25-031512.txt : 20250815 0001140361-25-031512.hdr.sgml : 20250815 20250815161353 ACCESSION NUMBER: 0001140361-25-031512 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20250813 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250815 DATE AS OF CHANGE: 20250815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solventum Corp CENTRAL INDEX KEY: 0001964738 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 922008841 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41968 FILM NUMBER: 251224786 BUSINESS ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 BUSINESS PHONE: 651-733-1110 MAIL ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 FORMER COMPANY: FORMER CONFORMED NAME: 3M Health Care Co DATE OF NAME CHANGE: 20230203 8-K 1 ef20054041_8k.htm 8-K false 0001964738 0001964738 2025-08-13 2025-08-13    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 13, 2025 SOLVENTUM CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-41968 92-2008841 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 3M Center, Building 275-6W 2510 Conway Avenue East Maplewood , MN 55144   (Address of principal executive offices) (Zip Code) ( 651 ) 733-1110 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of exchange on which registered Common Stock, $0.01 par value SOLV New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 8.01. Other Events. Underwriting Agreement On August 13, 2025, Solventum Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) by and among the Company, Goldman Sachs & Co. LLC and BofA Securities, Inc., as underwriters (the “Underwriters”), and 3M Company (the “Selling Shareholder”). The Underwriting Agreement relates to the sale of 8,800,000 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share, by the Selling Shareholder, subject to and upon the terms and conditions set forth therein. On August 15, 2025, the Selling Shareholder sold the Shares to the Underwriters pursuant to the Under